Quantum BioPharma Ltd. (QNTM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 23.99M |
| Enterprise Value | 23.96M |
| P/E Ratio | -0.4 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 24.88 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.37 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.07 |
| Return On Equity | -6.22 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -25.79M |
| Net Income | -26.18M |
| Diluted EPS | -8.11 |
| Total Cash | 10.07M |
| Total Cash/Share | 2.24 |
| Total Debt | 872,918 |
| Total Debt/Equity | 1.46 |
| Current Ratio | 0.63 |
| Book Value Per Share | -0.32 |
| 52-Week Change | -84.25 |
| 52-Week High | 31.91 |
| 52-Week Low | 2.07 |
| Moving Average 50 Days | 4.95 |
| Moving Average 200 Days | 6.96 |
| Average Volume | 357,830 |
| Shares Outstanding | 4.49M |
| % Held by Institutions | 7.74 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:65 |
| Last Split Date | August 15, 2024 |